Profil
David Westberg is currently the Chief Executive Officer & Managing Director at Nanexa AB since 2015.
He is also a Director at W & W Management & Design AB and an Independent Director at Lipigon Pharmaceuticals AB since 2023.
Previously, he worked as the Head-Product Development Department at Pharmacia AB, a Project Manager at Orexo AB, and a Manager-Project & Operations at LIDDS AB. Mr. Westberg graduated from the Royal Institute of Technology.
Aktive Positionen von David Westberg
| Unternehmen | Position | Beginn |
|---|---|---|
| NANEXA AB | Vorstandsvorsitzender | 01.04.2015 |
| LIPIGON PHARMACEUTICALS AB | Direktor/Vorstandsmitglied | 01.01.2023 |
W & W Management & Design AB | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David Westberg
| Unternehmen | Position | Ende |
|---|---|---|
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | - |
| OREXO AB | Corporate Officer/Principal | - |
| LIDDS AB | Geschäftsführer | - |
Ausbildung von David Westberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Orexo AB
Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Nanexa AB
Nanexa AB Medical SpecialtiesHealth Technology Operates as a research intensive technology company | Health Technology |
W & W Management & Design AB | |
Lipigon Pharmaceuticals AB
Lipigon Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops drugs aiming at treating dyslipidemia patients | Health Technology |
















